Close Menu

NEW YORK – The US Food and Drug Administration released its final guidance on Wednesday to streamline the process for reviewing in vitro diagnostic tests used in investigational cancer drug trials.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.